Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in
ABL Bio Inc banner
A

ABL Bio Inc
KOSDAQ:298380

Watchlist Manager
ABL Bio Inc
KOSDAQ:298380
Watchlist
Price: 184 400 KRW -2.54% Market Closed
Market Cap: ₩10.2T
Write Note Create Alert Ask AI
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Cash Flow Statement

Operating Cash Flow
+
3Y
-
5Y
+37%
10Y
-
Investing Cash Flow
+
3Y
+70%
5Y
-
10Y
-
Financing Cash Flow
+
3Y
+522%
5Y
+3 838%
10Y
-

Cash Flow Statement
ABL Bio Inc

Rotate your device to view
Cash Flow Statement
Currency: KRW
Mar-2018 Jun-2018 Sep-2018 Dec-2018 Mar-2019 Jun-2019 Sep-2019 Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Dec-2023 Mar-2024 Jun-2024 Sep-2024 Dec-2024 Mar-2025 Jun-2025 Sep-2025
Operating Cash Flow
Net Income
(78 044)
(171 474)
(178 004)
(117 234)
(120 062)
(28 817)
(27 828)
(37 005)
(45 667)
(53 226)
(57 972)
(55 606)
(49 694)
(43 385)
(40 653)
(43 558)
(43 229)
(33 056)
4 352
3 209
36 101
(2 647)
(38 952)
(50 361)
(102 899)
(55 529)
(71 706)
(20 522)
10 716
Depreciation & Amortization
533
500
552
621
825
1 092
1 380
1 649
1 787
1 869
1 970
2 064
2 148
2 200
2 174
2 158
2 142
2 161
2 220
2 325
2 433
2 590
2 582
3 174
3 758
2 410
2 353
2 727
3 091
Stock-Based Compensation
1 194
3 308
5 376
6 495
8 354
9 420
10 725
11 995
13 527
13 431
6 445
12 946
5 360
3 539
8 817
7 521
6 120
5 778
4 603
4 382
4 649
6 001
5 921
5 487
6 422
2 889
2 147
3 839
4 400
Other Non-Cash Items
67 079
161 155
162 671
100 026
100 274
7 422
6 697
9 213
10 165
7 454
6 429
9 625
8 163
6 959
7 049
9
118
833
(1 305)
7 275
4 955
7 474
9 284
9 776
49 254
2 038
2 268
3 152
(35 800)
Cash Taxes Paid
1
(4)
5
46
105
157
198
267
282
(26)
(29)
(113)
(153)
(73)
(60)
(76)
(82)
(5)
(49)
(3)
94
1 621
1 644
(24)
101
(1 346)
(1 418)
102
86
Cash Interest Paid
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1 205
1 826
2 521
2 379
2 848
3 455
165
0
(545)
(808)
Change in Working Capital
780
380
6 195
3 919
8 247
7 555
1 958
2 288
(1 392)
1 823
(3 185)
(3 378)
(4 694)
(8 132)
(3 416)
785
83 530
72 946
39 338
59 323
(31 258)
(35 779)
(33 469)
(41 510)
(46 996)
(18 322)
(13 163)
(8 941)
(11 192)
Cash from Operating Activities
(9 652)
N/A
(9 438)
+2%
(8 587)
+9%
(12 668)
-48%
(10 716)
+15%
(12 747)
-19%
(17 793)
-40%
(23 855)
-34%
(35 107)
-47%
(42 079)
-20%
(52 758)
-25%
(47 295)
+10%
(44 077)
+7%
(42 357)
+4%
(34 845)
+18%
(40 605)
-17%
42 562
N/A
42 885
+1%
44 605
+4%
72 132
+62%
12 230
-83%
(28 362)
N/A
(60 555)
-114%
(78 921)
-30%
(96 882)
-23%
(69 403)
+28%
(80 249)
-16%
(23 584)
+71%
(33 185)
-41%
Investing Cash Flow
Capital Expenditures
(1 079)
(1 085)
(1 159)
(1 318)
(3 093)
(3 480)
(3 717)
(3 839)
(2 106)
(1 543)
(1 108)
(631)
(523)
(592)
(930)
(1 266)
(1 485)
(1 405)
(1 017)
(3 637)
(3 588)
(5 844)
(7 221)
(9 327)
(11 096)
(9 058)
(14 830)
(21 192)
(21 456)
Other Items
(11 099)
7 664
(3 308)
(21 458)
(34 823)
(32 606)
(37 283)
(4 421)
(9 101)
10 556
11 929
(2 996)
13 019
(8 470)
19 401
21 487
1 816
(22 024)
(60 386)
(67 613)
(61 036)
35 728
51 546
58 746
88 222
(38 116)
(43 052)
30 275
3 057
Cash from Investing Activities
(12 178)
N/A
6 578
N/A
(4 467)
N/A
(22 776)
-410%
(37 915)
-66%
(36 087)
+5%
(41 000)
-14%
(8 260)
+80%
(11 207)
-36%
9 013
N/A
10 821
+20%
(3 627)
N/A
12 495
N/A
(9 062)
N/A
18 471
N/A
20 221
+9%
331
-98%
(23 429)
N/A
(61 404)
-162%
(71 250)
-16%
(64 624)
+9%
29 884
N/A
44 325
+48%
49 419
+11%
77 126
+56%
(47 174)
N/A
(57 882)
-23%
9 083
N/A
(18 399)
N/A
Financing Cash Flow
Net Issuance of Common Stock
0
69 993
69 993
159 993
160 645
90 652
90 652
652
1 497
1 497
1 497
1 497
1 256
1 256
1 256
1 256
4 348
5 021
5 021
5 753
1 847
1 717
0
2 372
142 372
145 857
148 955
147 858
26 006
Net Issuance of Debt
0
0
0
0
(135)
(285)
(485)
(691)
(765)
(820)
(850)
(886)
(922)
(958)
(967)
(959)
(952)
(952)
(998)
(1 091)
(1 176)
1 701
1 701
1 382
1 064
(1 278)
(1 278)
(1 245)
(977)
Other
0
(287)
(287)
(4 388)
(4 397)
(4 110)
(4 110)
(9)
(13)
(13)
(13)
(13)
(12)
(12)
(12)
(12)
(8)
(9)
(9)
(12)
(6)
(1 981)
0
(1 982)
(1 982)
(7)
(12)
(10)
(55)
Cash from Financing Activities
0
N/A
69 706
N/A
69 706
N/A
155 605
+123%
156 114
+0%
86 258
-45%
86 057
0%
(48)
N/A
719
N/A
664
-8%
634
-5%
598
-6%
322
-46%
285
-11%
277
-3%
284
+3%
3 388
+1 092%
4 060
+20%
4 014
-1%
4 649
+16%
665
-86%
1 437
+116%
996
-31%
1 771
+78%
141 453
+7 885%
144 572
+2%
147 665
+2%
146 603
-1%
24 974
-83%
Change in Cash
Effect of Foreign Exchange Rates
0
0
0
(123)
197
554
556
1 274
3 877
2 974
2 269
(165)
(2 055)
(2 028)
(815)
1 030
377
1 020
1 525
(1 984)
163
(30)
(2 160)
(2 522)
(2 552)
230
(160)
(310)
581
Net Change in Cash
(1 830)
N/A
66 846
N/A
56 652
-15%
120 039
+112%
107 680
-10%
37 978
-65%
27 819
-27%
(30 888)
N/A
(41 717)
-35%
(29 429)
+29%
(39 034)
-33%
(50 488)
-29%
(33 315)
+34%
(53 163)
-60%
(16 912)
+68%
(19 070)
-13%
46 657
N/A
24 536
-47%
(11 259)
N/A
3 547
N/A
(51 566)
N/A
2 929
N/A
(17 395)
N/A
(30 252)
-74%
119 144
N/A
28 225
-76%
9 374
-67%
131 792
+1 306%
(26 030)
N/A
Free Cash Flow
Free Cash Flow
(10 731)
N/A
(10 523)
+2%
(9 746)
+7%
(13 986)
-44%
(13 809)
+1%
(16 227)
-18%
(21 511)
-33%
(27 694)
-29%
(37 213)
-34%
(43 622)
-17%
(53 867)
-23%
(47 926)
+11%
(44 600)
+7%
(42 949)
+4%
(35 775)
+17%
(41 871)
-17%
41 076
N/A
41 480
+1%
43 588
+5%
68 495
+57%
8 642
-87%
(34 206)
N/A
(67 776)
-98%
(88 248)
-30%
(107 978)
-22%
(78 461)
+27%
(95 079)
-21%
(44 776)
+53%
(54 641)
-22%

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Follow us
Join more than 318,600+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.